Related Experiment Videos
Cytostatic Agents in the Management of Malignant Gliomas
1Henry Ford Midwest Neuro-Oncology Center, Department of Neurosurgery, Detroit, Ml 48202, USA.
Abstract:
BACKGROUND: Cytotoxic therapy for malignant gliomas is limited by poor delivery and drug resistance, and local therapy is ineffective in managing migratory cells. However, recent developments in malignant glioma therapy involve trials of cytostatic rather than conventional cytotoxic agents. METHODS: The biology of the brain extracellular matrix, tumor invasion, and angiogenesis are reviewed, and the cytostatic agents that inhibit matrix metalloproteinases, angiogenesis, cell proliferation, and signal transduction are discussed, as well as studies of the angiogenic and migratory capacity of malignant brain tumors. RESULTS: Two specific and interrelated areas, anti-invasion (migration) and anti-angiogenesis, are potential areas to develop new treatment strategies. Tumor invasion and angiogenesis are important components of the spread and biologic effects of malignant gliomas. Several proteinase inhibitors are in clinical trial, as well as anti-angiogenic agents and signal transduction cascade inhibitors. CONCLUSIONS: Biologic control of brain tumor cell populations may offer a new management approach to add to currently available management options for malignant brain tumors.
Insights
New malignant glioma therapies focus on cytostatic agents to inhibit tumor invasion and angiogenesis. This approach aims to improve treatment by targeting tumor cell spread and blood vessel formation, offering a novel management strategy.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Pharmacology
Background:
- Cytotoxic therapy for malignant gliomas faces challenges with drug delivery and resistance.
- Local therapies are insufficient for managing migratory tumor cells.
- Emerging malignant glioma treatments explore cytostatic agents over conventional cytotoxic drugs.
Purpose of the Study:
- To review the biology of brain extracellular matrix, tumor invasion, and angiogenesis in malignant gliomas.
- To discuss cytostatic agents targeting matrix metalloproteinases, angiogenesis, proliferation, and signal transduction.
- To examine the angiogenic and migratory potential of malignant brain tumors.
Main Methods:
- Literature review of brain extracellular matrix biology, tumor invasion, and angiogenesis.
- Analysis of cytostatic agents' mechanisms of action.
- Review of studies on malignant brain tumor angiogenesis and migration.
Main Results:
- Anti-invasion and anti-angiogenesis strategies show promise for new treatment development.
- Tumor invasion and angiogenesis are key factors in malignant glioma progression.
- Several proteinase inhibitors, anti-angiogenic agents, and signal transduction inhibitors are in clinical trials.
Conclusions:
- Biologic control of brain tumor cell populations presents a potential new management approach.
- This strategy could complement existing treatment options for malignant brain tumors.